14.7% Below Target

Thermo Fisher Scientific Inc. (TMO) has a consensus 12-month price target of $592.45, implying 14.7% upside from $516.62. The 42 analysts covering TMO see moderate appreciation potential.

TMO has a consensus rating of "Buy" based on 42 Wall Street analysts. The rating breakdown is predominantly bullish, with 37 Buy/Strong Buy ratings. The consensus 12-month price target of $592.45 implies 14.7% upside from current levels.

TMO trades at a forward P/E of 20.785x, representing a moderate valuation. With analysts targeting $592.45 (14.7% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $683 for TMO, while the most conservative target is $490. The consensus of $592.45 represents the median expectation. Our quantitative valuation model projects a bull case target of $818 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

TMO is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 37 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month TMO stock forecast based on 42 Wall Street analysts shows a consensus price target of $592.45, with estimates ranging from $490 (bear case) to $683 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $621, with bear/bull scenarios of $391/$818.

Our quantitative valuation model calculates TMO's fair value at $621 (base case), with a bear case of $391 and bull case of $818. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

TMO trades at a forward P/E ratio of 20.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 29.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on TMO, with a "Buy" consensus rating and $592.45 price target (14.7% upside). 37 of 42 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

TMO analyst price targets range from $490 to $683, a 33% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $592.45 consensus represents the middle ground. Our model's $391-$818 range provides an independent fundamental perspective.